Gastric Emptying

Gastric Emptying

Gastric emptying refers to the process by which the stomach propels its contents into the duodenum through coordinated contractions of the gastric musculature and regulated opening of the pyloric sphincter. The rate of gastric emptying is a critical determinant of postprandial glucose excursions, as it controls the speed at which carbohydrates reach the absorptive surface of the small intestine. Under normal conditions, a mixed meal empties from the stomach over approximately two to four hours, though this rate varies based on meal composition, volume, and individual physiological factors.

Slowing gastric emptying is one of the key mechanisms by which GLP-1 receptor agonists exert their therapeutic effects. When GLP-1 receptors in the gastrointestinal tract are activated, they delay the rate at which food leaves the stomach, resulting in more gradual nutrient absorption, lower postprandial glucose peaks, and prolonged feelings of fullness or satiety. Retatrutide, through its GLP-1 receptor agonist component, slows gastric emptying as part of its multi-receptor mechanism of action. This effect contributes both to the drug’s glucose-lowering properties in patients with type 2 diabetes and to its appetite-suppressing effects in obesity treatment.

The impact on gastric emptying also underlies some of the most common side effects associated with incretin-based therapies. Nausea, vomiting, and other gastrointestinal symptoms are thought to result in part from the delayed transit of food through the stomach. This is why dose escalation protocols are employed — by gradually increasing the dose, the gastrointestinal system can partially adapt to the altered motility patterns, improving tolerability over time while maintaining the therapeutic benefits of delayed gastric emptying.